Neurotech Pharma's cell therapy Encelto has become the first FDA-approved treatment for idiopathic macular telangiectasia ...

Systemic manifestations of gnathostomiasis can affect the skin, brain, gastrointestinal tract and respiratory system, while ocular involvement is rare. 5 Intraocular gnathostomiasis, though uncommon, ...